Pharmacological interference with hepatic glucose production.
Burger
H J
HJ
Hoechst Marion Roussel Deutschland GmbH, Frankfurt am Main, Germany. hans-joerg.burger@hmrag.com
Schubert
G
G
Hemmerle
H
H
Kramer
W
W
Herling
A W
AW
D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005943:Gluconeogenesis / Q000187:drug effects*; D005947:Glucose / Q000096:biosynthesis / Q000378:metabolism*; D005952:Glucose-6-Phosphatase / Q000037:antagonists & inhibitors; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects* / Q000378:metabolism*; D019764:Phosphoenolpyruvate Carboxykinase (ATP) / Q000037:antagonists & inhibitors; D006005:Phosphorylases / Q000037:antagonists & inhibitors; D010848:Picolinic Acids / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats
D004791:Enzyme Inhibitors; D007093:Imidazoles; D010848:Picolinic Acids; D011725:Pyridines; C403582:S 4048; C008363:3-mercaptopicolinic acid; D006005:Phosphorylases; D005952:Glucose-6-Phosphatase; D019764:Phosphoenolpyruvate Carboxykinase (ATP); D005947:Glucose